 - Unwilling or unable to use reliable methods of contraception from four weeks prior to Day 0 throughout three months after Treg dosing males or for two years after Treg dosing females. Note: investigators of female participants of childbearing potential on concurrent MMF, and those participants themselves, whether or not they plan to become pregnant, are strongly encouraged to participate in Mycophenolate Risk Evaluation and Mitigation Strategy REMS. 